Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 5/20 | 0.41 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | AGER | Q15109 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21719010 | 0.83 | ALDH1A1 (0.47) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL9638077 | 0.82 | ALDH1A1 (0.50) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL21718975 | 0.82 | MAPT (0.42) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL472133 | 0.82 | CA12 (0.43) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30331506 | 0.82 | ALDH1A1 (0.50) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL21718991 | 0.82 | AGER (0.43) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL21719006 | 0.82 | MAPT (0.42) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL21718995 | 0.82 | MAPT (0.42) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL22140233 | 0.81 | ALDH1A1 (0.52) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL21718853 | 0.78 | MAOB (0.42) | MAPTLMNAMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9701874-B2 | Conductive adhesive, anisotropic conductive film, and electronic device using same | SHOWA DENKO K.K. (JP) | 2017-07-11 | — | — | US | claimed |
| EP-2982727-B1 | CONDUCTIVE ADHESIVE, ANISOTROPIC CONDUCTIVE FILM AND ELECTRONIC DEVICES USING BOTH | SHOWA DENKO KK (JP) | 2020-09-02 | — | — | EP | disclosed |
| US-9701874-B2 | Conductive adhesive, anisotropic conductive film, and electronic device using same | SHOWA DENKO K.K. (JP) | 2017-07-11 | — | — | US | disclosed |
| US-20160060490-A1 | CONDUCTIVE ADHESIVE, ANISOTROPIC CONDUCTIVE FILM AND ELECTRONIC DEVICES USING BOTH | SHOWA DENKO K.K. (JP) | 2016-03-03 | — | — | US | disclosed |
| EP-2982727-A1 | CONDUCTIVE ADHESIVE, ANISOTROPIC CONDUCTIVE FILM AND ELECTRONIC DEVICES USING BOTH | Showa Denko K.K. (JP) | 2016-02-10 | — | — | EP | disclosed |
| US-8759553-B2 | Method for producing epoxy compound | SHOWA DENKO K.K. (JP) | 2014-06-24 | — | — | US | disclosed |
| US-8664414-B2 | Process for producing epoxy compound | SHOWA DENKO K.K. (JP) | 2014-03-04 | — | — | US | disclosed |
| US-20130116455-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | SHOWA DENKO K.K. (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20120029217-A1 | PROCESS FOR PRODUCING EPOXY COMPOUND | SHOWA DENKO K.K. (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2412712-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | Showa Denko K.K. (JP) | 2012-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029217-A1 | PROCESS FOR PRODUCING EPOXY COMPOUND | NOX4, NOX5, NOXO1 | MAPT 3941/4885LMNA 4828/4885MEN1 3910/4885 |
| US-20130116455-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | DUOX2, EPHX2, AOX1 | MAPT 4652/4885LMNA 3317/4885MEN1 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.